Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00931502 · ClinicalTrials.gov registry record

Stent Thrombosis In Acute Coronary Syndromes

A clinical trial, sponsored by University of California, Davis.

Completed
Registry status
800
Enrollment target

NCT00931502: Completed study, sponsored by University of California, Davis.

NCT00931502 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 800 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00931502 has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
800 participants
Enrollment target

Study Summary

The purpose of this study is to better understand what treatment methods result in the best outcomes for patients who have heart attacks due to blood clots forming within stents.

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2008-04
Est. Completion 2017-02
University of California, Davis

657 total trials

What the finished NCT00931502 record still lists

NCT00931502 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00931502 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00931502 about?

NCT00931502 is a clinical study titled "Stent Thrombosis In Acute Coronary Syndromes". The purpose of this study is to better understand what treatment methods result in the best outcomes for patients who have heart attacks due to blood clots forming within stents.

What is the current status of trial NCT00931502?

This trial is currently completed. The enrollment target is 800 participants. The study started on 2008-04. Estimated completion is 2017-02.

Who is sponsoring clinical trial NCT00931502?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00695214 · 800 participants · Phase 2

    Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea

  • NCT03048201 · 800 participants · NA

    Physica System Total Knee Replacement Registry Study

  • NCT03792659 · 800 participants

    The EXPLORE MG Registry for Myasthenia Gravis

  • NCT03819296 · 800 participants · Phase 1

    Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00931502, the US trial registry maintained by the National Library of Medicine. NCT00931502 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.